Scientists reverse cell aging in mice, delaying ALS onset
Genetically reprogramming nerve cells to reverse aging may be a viable strategy for treating amyotrophic lateral sclerosis (ALS), a…
Articles by Marisa Wexler, MS
Research sheds new light on ALS gene mutation
Researchers at Yale School of Medicine said they’ve solved a longstanding mystery of how mutations in the C9ORF72 gene, a common…
Wearable robot gives ALS patients a hand
A wearable robot that detects small arm motions and helps support the shoulder can make it easier for amyotrophic…
Measuring electrical activity of neck muscles may be new tool in ALS
Measuring the electrical activity of muscles in the neck can help clinicians to identify dysfunction in certain motor neurons —…
Advocates ask for new FDA review of stem cell therapy NurOwn
A coalition of amyotrophic lateral sclerosis (ALS) patients and their family members has filed a petition to the U.S.
9 of 10 NurOwn-treated ALS patients surpass five-year survival
Nine out of 10 people with amyotrophic lateral sclerosis (ALS) who received the experimental cell therapy NurOwn (debamestrocel)…
Dazucorilant significantly extends survival in Phase 2 ALS trial
Dazucorilant, an oral cortisol modulator being developed by Corcept Therapeutics, significantly improved survival among people with amyotrophic lateral sclerosis (ALS)…
Brain-computer interface allows man with ALS to talk in real time
An investigational brain-computer interface has allowed a man diagnosed with amyotrophic lateral sclerosis (ALS) to speak in real…
Bipartisan congressional effort calls for increased ALS research funding
A bipartisan team of U.S. congressional legislators is calling for increased funding to support research seeking to better understand and…
Treatment with jacifusen shows benefits for some FUS-ALS patients
Treatment with the experimental therapy jacifusen was generally well tolerated and appeared to slow or even reverse disease progression in…